By the end of 2022, Australia’s respirator mask and surgical market can be worth US$ 167.7 Mn. This growth attributes to an increase in the frequency of surgical procedures and the incidence of infectious diseases. The development in the government’s concern over the health of the populace is projected to enhance the market in these regions. THe anticipation is that the influx of investments by foreign companies into the markets of Australia would open up new income opportunities for the manufacturers. As a consequence of the COVID-19 outbreak, the face mask made in the Australia market has benefited because mask demand has skyrocketed. During this pandemic, there is a prediction that the market will expand significantly. In the upcoming years, public and private hospitals are anticipated to make considerable financial contributions. With new players entering the market during the COVID-19 pandemic, the rivalry can become more fierce. Significant businesses are working together with other participants to improve their market presence.
The Drivers Of the Market
The need for surgical and respiratory masks is rising as infections that spread through touch, droplets, or air become more common. Medical equipment used to cover the mouth and nose to shield patients, and healthcare professionals from the spread of such diseases is in high demand in the medical industry across the globe.
The market for surgical respiratory masks is growing in Australia due to various causes, including increased surgical operations, product improvements, and rising healthiness and hygiene problems. The Australian market, estimated to be worth US$103.9 million, is anticipated to expand at a healthy rate over the next ten years.
To bridge the gap between rising demand, businesses have also improved production and manufacturing capabilities, opening new avenues for income growth. The 3M Company, Smith & Nephew Plc, Ansell Healthcare LLC, and Medline Industries, Inc. are notable companies covered in the global market.
How is the market segmented?
Day surgery centres, general practitioners, life science experts, independent dental surgeons, nursing homes, and veterinary surgeons are the several end-user categories into which the respiratory mask market may be divided.
Among all the aforementioned, hospitals are expected to lead the market in revenue generation. There are several different types of masks on the market, including the standard surgical mask, fluid/splash-resistant masks, and anti-fog foam masks, with splash-resistant masks accounting for most sales. In October 2020, 53.8% of Australians reported wearing a protective mask in the previous week.
Medical equipment used to cover the mouth, nose, and chin to shield patients and healthcare workers from droplets and massive respirator particles are referred to as surgical and respirator masks. Medical personnel and life science professionals primarily utilise respirator masks in hospitals and day surgery facilities.
Trends of market
From US$ 134.9 Mn in 2014 to US$ 167.7 Mn in 2021, the surgical mask market in Australia is projected to increase at a CAGR of 3.3%. The surgical mask markets in both nations are anticipated to benefit from rising health and hygiene concerns and an increase in surgical operations.
Australia’s surgical and P2 mask market’s valuation at $1.2 billion in 2014. The surgical and P2 mask market in Australia was worth US$ 103.9 million in 2014, and by the end of 2015, it is anticipated to be worth US$ 106.2 million.
It is anticipated that the market of face mask made in Australia in these places will rise as governments’ concerns about the population’s health increase. Anticipation is there that the influx of investments by foreign companies into the markets of Australia would open up new income opportunities for the manufacturers.